AstraZeneca is a company with a turbulent history ... which included activities in biocides, industrial colours, lifescience modules, performance and intermediate chemicals. It was this decision ...

Derren Nathan, head of equity research at Hargreaves Lansdown, said: “AstraZeneca has passed its first quarter health check with flying colours. “Its drive to roll out next-generation cancer ...

EU backs AstraZeneca, Daiichi's Enhertu for breast cancer treatment post endocrine therapy The European Union's health regulator on Friday backed AstraZeneca and Daiichi Sankyo's drug Enhertu as a ...